医学
皮疹
皮肤病科
耐火材料(行星科学)
免疫学
皮肤损伤
疾病
补体缺乏
系统性红斑狼疮
红斑狼疮
补体成分2
补体系统
非典型溶血尿毒综合征
多系统疾病
自身免疫性疾病
遗传性血管水肿
经典补体途径
霉酚酸酯
颧骨皮疹
替代补体途径
结缔组织病
复合杂合度
遗传病
作者
Aybuke Alisan,Nergis Akay,Rabia Miray Kışla Ekinci,Mehmet Yıldız,Sezgin Şahin,Kenan Barut,Ozgur Kasapcopur
标识
DOI:10.1177/11795441261500134
摘要
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease exhibiting clinical heterogeneity among affected individuals. In monogenic lupus, which results from single-gene mutations, there is an early onset, atypical and severe course, and usually a familial predisposition. One of the common causes of monogenic SLE is deficiencies in the early components of the classical pathway of the complement system. We present here a 9-year-old male with hereditary C1R deficiency, suffering from chronic discoid rash since the age of 18 months, who did not sufficiently respond to conventional treatment, including topical and systemic steroids, hydroxychloroquine, mycophenolate mofetil, intravenous immunoglobulin, and baricitinib. Subsequently, the skin findings improved after the initiation of anifrolumab, an anti-IFNAR antibody. To the best of our knowledge, this report represents the first successful treatment of monogenic lupus and C1R deficiency with anifrolumab in the literature.
科研通智能强力驱动
Strongly Powered by AbleSci AI